Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

JSR Set to Offer Pre-Clinical Trial Services Using Cancer Organoids in Japan

Filed Under: Pharma Tagged With: , , , ,

JSR Corp. (TYO:4185) is working on the Japanese launch of pre-clinical trial services that utilize cancer organoids, which are tumor-derived…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

JSR Pursues New Developments in Life Sciences Business
JSR Pursues New Developments in Life Sciences Business
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report – Part 33: Japan Eyes Development of Five Potential Treatments
Coronavirus Report – Part 33: Japan Eyes Development of Five…
Just How Effective Will Vaccines Be in Combating the COVID-19 Pandemic?
Just How Effective Will Vaccines Be in Combating the…
U.S.–Japanese Research Team Creates Multi-Organ Structure From Human iPS Cells
U.S.–Japanese Research Team Creates Multi-Organ Structure…
Tokyo Tech Works on New Form of Photodynamic Cancer Treatment
Tokyo Tech Works on New Form of Photodynamic Cancer…